Psyomics Ltd was incorporated in March 2015. It was founded by Professor Sabine Bahn and Dan Cowell with the aim of building a diagnostics company focused on improving patient outcomes for those with psychiatric disorders. Psyomics will leverage the expertise, know-how and IP of the Bahn lab at the University of Cambridge to generate value through the validation of biomarker panels discovered in the Bahn lab. Psyomics intends to develop combined digital and blood biomarker tests for early and improved diagnosis of major psychiatric disorders.